The Carbs & Cals Flashcards are a visual guide to counting carbs, calories and other nutrients in a range of popular food and drinks. Each of the 64 large, durable cards displays a food photo and portion weight. The reverse of the card shows the same photo with its nutritional information. NEW FEATURE for this edition: The amount of carbs are also displayed as blood glucose icons, to visually show the possible effect of each portion on blood glucose levels. Carbs & Cals Flashcards are perfect for diabetes, weight loss and portion control, and can be used in a variety of ways at home or in a clinical setting. Use alongside the Carbs & Cals PACK 2 and WORLD FOODS flashcard sets, to make a bumper pack of 192 unique flashcards!

This book presents the state of the art of type 2 diabetes genetics, from the process of genetic discovery to its interpretation and clinical application, and illustrates a model for other complex human phenotypes.The first section explores genome-wide association studies, the extension of this method to less accessible phenotypes and the arrival of next-generation sequencing. A further section goes beyond genetics to illustrate how other data sources can help interpret genetic data, such as leveraging population diversity, the correlation of genetic associations with physiological measurements, gene expression modulation, environmental factors and our microbial commensals. The third section describes advances in elucidating the complex path from association to function using in-depth sequencing and functional studies of the cellular and molecular effects of genes in the loci identified by genetics. The final section links our current understanding with clinically relevant questions, such as prediction, interactions with drugs or nutrients, and disease prevention, and paints a realistic but hopeful vision of the future.

This issue of Critical Care Nursing Clinics, Guest Edited by Celia Levesque RN, MSN, NP-C, CNS-BC, CDE, BC-ADM, from MD Anderson, will focus on Diabetes. Article topics will include Management of Diabetes in the Clinical Setting, Hyperglycemia management after solid organ transplantation, Insulin therapy in the hospitalized patient, Limb salvage for Vetrans with diabetes, and Management of steroid induced hyperglycemia in the ICU.

It is 1919 and Elizabeth Hughes, the eleven-year-old daughter of America's most-distinguished jurist and politician, Charles Evans Hughes, has been diagnosed with juvenile diabetes. It is essentially a death sentence. The only accepted form of treatment - starvation - whittles her down to forty-five pounds skin and bones. Miles away, Canadian researchers Frederick Banting and Charles Best manage to identify and purify insulin from animal pancreases - a miracle soon marred by scientific jealousy, intense business competition and fistfights. In a race against time and a ravaging disease, Elizabeth becomes one of the first diabetics to receive insulin injections - all while its discoverers and a little known pharmaceutical company struggle to make it available to the rest of the world.

Relive the heartwarming true story of the discovery of insulin as it's never been told before. Written with authentic detail and suspense, and featuring walk-ons by William Howard Taft, Woodrow Wilson, and Eli Lilly himself, among many others.

Neurons share more similarities with insulin-producing pancreatic islet cells than with any other cell type. The root of this similarity may lie in the islet's evolution from an ancestral insulin-producing neuron. The islet-neuron connection becomes less surprising as we learn more about insulin's involvement in functions far from its traditional role in mediating glucose uptake in muscle. The importance of insulin in the regulation of corporal aging has been established by the dramatic increases in longevity experienced by animals in which the adipose insulin receptor has been genetically eliminated, or in which the insulin-related daf genes have been mutated. New research suggests that, analogous to its influence on corporal aging, insulin also makes important contributions to brain aging and the expression of late-life neurodegenerative disease. Insulin plays a key role in cognition and other aspects of normal brain function. Insulin resistance induces chronic peripheral insulin elevations and is associated with reduced insulin activity both in periphery and brain. The insulin resistance syndrome underlies conditions such as Type 2 diabetes mellitus and hypertension, which are associated with age-related cognitive impairment and Alzheimer's disease. This book discusses the mechanisms through which insulin dysregulation contributes to the development of cognitive impairment and late-life neurodegenerative disease. Given the recent pandemic of conditions associated with insulin resistance, it is imperative that we achieve a comprehensive knowledge of the mechanisms through which insulin resistance affects brain function in order to develop therapeutic strategies to address these effects.

The second edition of this atlas is a complete guide to the diagnosis and management of endocrine disorders, including diabetes. Presented as a collection of clinical cases, the book has been fully revised to provide trainees with the most up to date information and latest advances in the field. Divided into seven sections, topics cover thyroid, diabetes, the adrenal and pituitary glands, bone, reproductive issues, and a selection of growth and other metabolic disorders. Cases are presented in a step by step approach explaining pathology, history, symptoms, imaging, diagnosis, and treatment. Each section features multiple choice questions to test understanding, numerous images and illustrations, and suggestions for further reading. Key points Complete guide to diagnosis and management of endocrine disorders including diabetes Fully revised, new edition detailing latest advances in the field Presented as clinical cases with multiple choice questions Previous edition (9789351528579) published in 2016

In Diabetes & C-Peptide: Scientific and Clinical Aspects, a renowned group of leading researchers and physicians offers a comprehensive overview of the role of C-Peptide in type 1 diabetes. The book is organized in five sections. An Introductory section provides the background and key features of C-peptide's physiological function and how its deficiency contributes to complications. The second section describes up-to-date information on the biochemical and molecular actions of C-peptide, including membrane binding, interactions with insulin as well as the interaction between C-peptide and zinc and effects on microvascular vasoreactivity. The third section summarizes in vivo animal studies of the type 1 diabetic complications. The fourth section reviews the clinical efforts of C-peptide on inflammation, cardiovascular complication, neuropathy and nephropathy. Finally, in the Conclusions section, a summary of the present state of C-peptide, outstanding questions, and the likely direction of the field are offered. Developed by the foremost investigators in the rapidly moving field of C-peptide research, Diabetes & C-Peptide: Scientific and Clinical Aspects is an important contribution to the literature for all researchers and physicians concerned about type 1 diabetes.

People with diabetes are two to four times more likely to develop cardiovascular disease.? Insulin resistance, which leads to diabetes in 1 in 4 people who have it, affects 60 million Americans and is also a cardiovascular disease risk factor.? It is important for cardiologists to understand the reasons why diabetes and insulin resistance cause increased cardiovascular risk so they can help their patients control these risk factors.

More than just coincidence connects a Tate & Lyle lawsuit and artificial sweetener to Jamaican-born Chemist Bert Fraser-Reid. From his first experience of Chemistry through his diabetic father, to his determination and drive as a Chemistry student in Canada, Fraser-Reid weaves a remarkable tale integrating science, law and autobiographical anecdotes. This book arises from the lawsuit brought by Tate & Lyle against companies accused of infringing its patents for sucralose, the sweet ingredient in the artificial sweetener SPLENDA which is made by chlorinating sugar. From a 1958 undergraduate intern witnessing the pioneering experiments on sugar chlorination, to being the 1991 recipient of the world's premiere prize for carbohydrate chemistry, Fraser-Reid was groomed for his role as expert witness in the mentioned lawsuit. Nevertheless, it seems more than his career links Fraser-Reid to the case.

Great-Tasting Food for People with Diabetes and their Families
Revised and updated to reflect the latest recommendations from The American Diabetes Association and The American Dietetic Association, "The New Family Cookbook for People with Diabetes "remains the most authoritative and comprehensive resource available for people with diabetes and their families.
With more than 370 healthful and flavorful recipes accompanied by complete nutritional analysis, this book makes it easy to prepare satisfying and delicious meals that the whole family will enjoy.
RECIPES INCLUDE:
Whole Wheat Blueberry Rice Pancakes - Baked Orange French Toast
Black Bean and Cilantro Spread - Honey-Mustard Chicken Wings
Curried Chicken Salad - Marinated Skirt Steak with Vegetable Chutney
Lamb Over Minted Couscous - Italian Turkey Sausage with Peppers and Onions
Baked Salmon with Horseradish Mayonnaise - Sugar Snap Peas with Basil and Lemon
Baked Potato Skins - Rum Baked Black Beans - Apple Raspberry Crisp
Port-Poached Pears - New York Cheesecake - Raisin Rice Pudding

"Advances in Immunology, " a long-established and highly respected publication, presents current developments as well as comprehensive reviews in immunology.
This thematic volume focuses on the immunopathogenesis of type 1 diabetes mellitus. Edited and authored by the foremost scientists in this field, it provides up-to-date information and directions for future research.

This book is intended to provide up-to-date and emerging information in the field of diabetes mellitus with a focus on preventive, predictive and personalized medicine.

As one of the three major diseases in the Western world, and one that is on the increase, care of people with diabetes is crucial to the entire healthcare team. This book provides a comprehensive text on the management of the person with diabetes in the community and will be invaluable to dietitians, podiatrists and GPs and especially to practice nurses, district nurses and health visitors. It has been written from a community perspective by a multiprofessional team and advocates principles of care based on the latest research. It focuses on the role of the professional in assisting in self-care of the individual with diabetes. It also includes caring for the person in long-term care settings, for example, nursing homes. The comprehensive text establishes 'why' as well as 'what' you need to know The focus on community ensures its relevance Case study scenarios provide practical content, centred on people with diabetes Issues relating to ethnic minorities are incorporated throughout The evidence base ensures the latest research is incorporated and relates it to clinical practice Useful references and websites encourage wider reading . Fully updated content to include new information and developments in clinical practice . Case study scenarios have been expanded to enhance the usefulness of the book . Issues relating to ethnic minorities will be incorporated throughout the book . All references updated and useful websites added

This contributed volume presents computational models of diabetes that quantify the dynamic interrelationships among key physiological variables implicated in the underlying physiology under a variety of metabolic and behavioral conditions. These variables comprise for example blood glucose concentration and various hormones such as insulin, glucagon, epinephrine, norepinephrine as well as cortisol. The presented models provide a powerful diagnostic tool but may also enable treatment via long-term glucose regulation in diabetics through closed-look model-reference control using frequent insulin infusions, which are administered by implanted programmable micro-pumps. This research volume aims at presenting state-of-the-art research on this subject and demonstrating the potential applications of modeling to the diagnosis and treatment of diabetes. The target audience primarily comprises research and experts in the field but the book may also be beneficial for graduate students.

Deciphers amylin's physiology and reveals previously unrecognized mechanisms fundamental to control body weight and fuel homeostasis. Also discusses therapeutic utility of amylin as the first new medicine to treat diabetes since insulin.
*Provides a current comprehensive treatment of amylin the hormone
*Identifies the majority of amylin's physiologic functions

In recent years, human studies have made enormous contributions towards an understanding of the genetic basis of diabetes mellitus; however, most of the experimentation needed for the invention and testing of novel therapeutic approaches cannot be performed in humans. Thus, there is no alternative to appropriate animal models. In Animal Models in Diabetes Research, expert researchers explore the current status of the most important models and procedures in order to provide a timely resource in experimental diabetology. The first half of the volume serves as a comprehensive overview on our current knowledge of the pathogenesis and pathophysiology of diabetes in animal models through a series of reviews in model strains. The book then continues with vital, established protocols that are employed in the characterization and study of animal models of diabetes. As a volume in the highly successful Methods in Molecular Biology (TM) series, this work contains the type of detailed description and key implementation advice necessary to achieve successful results. Authoritative and cutting-edge, Animal Models in Diabetes Research delivers essential content that will be an important resource to advance diabetes research in the years to come.

The growing problem of diabetes presents difficult challenges for sufferers and for those in the healthcare professions, who are in the unenviable position of trying to convince patients to change their lifestyle "for their own good." Handbook of Diabetes Management provides practical knowledge and advice that can help you anticipate the challenges of working with these Patients. What's more, since the knowledge here is evidence-based, you can assure your patients that the guidelines you're presenting to them have been shown to be effective.

This guide takes into account the complexity of the disease, the diversity of the populations it affects, and the continued improvement of care systems. It discusses the origins of diabetes and medication management and treatment, then presents advice based on the latest research findings on:

-behavioral health and self-management issues and interventions

-tips for patients dealing with issues such as travel, surgery, and foot care

-treating specific patient populations including Latinos, Native Americans, rural communities, and the uninsured

-case studies from successful, replicable programs

Also addressing the business aspects of diabetes care related to such areas as legal and regulatory issues and health policy initiatives, Handbook of Diabetes Management, brings you practical insights based on the latest research.

"This handbook book by expert professionals covers every aspect of diabetic care. It is a sound, evidence-based, culturally informative, practical approach to diabetes prevention and disease management."

-Kathleen Lambert, BSN, RN, JD, from the Foreword

When new fellows join my lab, I give them some reading materials so that they can orient themselves in their assignment in a new eld. When fellows leave my lab, some after writing their dissertations, I prefer to give them a book as a symbolic present. I was longing for a book that contained something on more or less eve- thing about the islets. At the same time, I wished it contained information as recent as possible. There are a few such books in the market but they are pretty outdated. I started picking islets myself from October 1990, when I joined the Rolf Luft Center, Karolinska Institutet. Over the years my fascination for islet research remained high. Since last year, I felt a stronger urge to do more for these mysterious and hidden mini-organs that are directly or indirectly involved in the pathogenesis of all forms of diabetes that affects ?250 million people in the world. After I launched the Islet (landesbioscience. com/journals/islets) and founded the Islet Society (isletso- ety. org), there was a momentum that could be utilized to create something equally meaningful i. e. this book. The idea cracked in September 2008. Starting September 19, 2008, I contacted an estimated 90% of the authors who published anything on the islets during 2007-2008 and who could be traced from the internet.

The aim of this volume is to present current methodologies to predict and understand the pathogenesis of Type-1 Diabetes for clinical and non-clinical researchers. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls. Practical and reliable, Type-1 Diabetes: Methods and Protocols will aid researchers in using these methods to advance their own studies.

This book will assemble the views of many of the world's experts in the field of viruses and diabetes. It will look critically at some unanswered questions, in the field. Among these, How do viruses destroy or modify the pancreatic islet? Which viruses are involved? What is the role of virus-induced cytokines> Could vaccines prevent virus-induced diabetes? Until recent technological advances, progress in the understanding of the relationship between viruses and diabetes has been hampered. New technologies are helping shed new light on these mysteries. This will be the first comprehensive volume on this topic.

An essential reference for any laboratory working in the analytical fluorescence glucose sensing field. The increasing importance of these techniques is typified in one emerging area by developing non-invasive and continuous approaches for physiological glucose monitoring. This volume incorporates analytical fluorescence-based glucose sensing reviews, specialized enough to be attractive to professional researchers, yet appealing to a wider audience of scientists in related disciplines of fluorescence.

An unprecedented compilation of state-of-the-art advances in clinical research by premier clinical scientists around the world. This volume discusses the methods of clinical research and the interpretation of their results in studies of normal individuals, obese subjects, and patients with diabetes mellitus. Along the way, the authoritative contributors writing here illuminate how changes in the hormone action and substrate metabolism of healthy humans may lead to obesity and noninsulin-dependent diabetes mellitus.

Medical Applications of Electrochemistry, a volume of the series Modern Aspects of Electrochemistry, illustrates the interdisciplinary nature of modern science by indicating the many current issues in medicine that are susceptible to solution by electrochemical methods. This book also suggests how personalized medicine can develop.

An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied. Developed by a renowned group of authorities, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers responses and context for a range of questions, such as: do metabolic factors beyond glucose contribute to vision-threatening diabetic retinopathy? If so, how do these lead to vision impairment? Is diabetic retinopathy a response to systemic metabolic abnormalities or are there unique ocular problems related to insulin resistance? What is the relationship between the neural, vascular, and inflammatory abnormalities in diabetic retinopathy? Do they represent a pathological cascade induced sequentially or simultaneous responses to one or more metabolic perturbations? The authors note that if we do not address these types of questions, it is possible that the long process of developing new therapeutic s will target only one arm of the pathology and leave the retina open to damaging consequences of the others. State-of-the-art, comprehensive, and an invaluable addition the research and clinical literature, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers guidance and a significant step toward new scientific approaches that can lessen the devastating vision impairment associated with diabetes.